Ondansetron plus dexamethasone in the control of high dose cisplatin-induced emesis

J Chemother. 1993 Feb;5(1):60-2. doi: 10.1080/1120009x.1993.11739212.

Abstract

Twenty-two patients who underwent chemotherapy with cisplatin (CDDP) at doses > 100 mg/m2 also received antiemetic treatment comprised of the combination of ondansetron plus dexamethasone. The results obtained have shown a good activity from this combination with these high doses of CDDP, with a response of 81.8% (complete+major protection). There were also three therapeutic failures in patients with a few negative prognostic characteristics. It is our intention to use a benzodiazepine and adequate psychological support in an attempt to increase the response percentages in these kinds of patients.

MeSH terms

  • Adult
  • Aged
  • Cisplatin / adverse effects*
  • Dexamethasone / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nausea / chemically induced
  • Nausea / drug therapy
  • Ondansetron / therapeutic use*
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Ondansetron
  • Dexamethasone
  • Cisplatin